Á¦59ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-11-03
±³À°ÀÏÀÚ : 2023-11-03
±³À°Àå¼Ò : ¼¿ï, ÄÜ·¡µåÈ£ÅÚ(¿©Àǵµ) 3Ãþ
±³À°ÁÖÁ¦ : (¿ÀÇÁ¶óÀÎ) Á¦59ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : ¼Áö¿ø
¿¬¶ôó : 02-565-3350
À̸ÞÀÏ : ksh@koreanhypertension.org
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, °¡Á¤ÀÇÇаú, »ý¸®ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í "*»çÀüµî·Ï: Á¤È¸¿ø(6¸¸¿ø), Á¤È¸¿ø ¿Ü(8¸¸¿ø), ÀüÀÓÀÇ ¹× ±âŸ(4¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)
*ÇöÀåµî·Ï: Á¤È¸¿ø(8¸¸¿ø), Á¤È¸¿ø ¿Ü(10¸¸¿ø), ÀüÀÓÀÇ ¹× ±âŸ(5¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 09:15~09:30 Pathophysiology of Hypertension for Novel Treatment À±Á¾Âù(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 09:30~09:45 Development of Therapeutic Vaccine for Hypertension Hironori Nakagami(japan)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 09:45~10:00 SiRNA and Other Novel Therapeutics for Hypertension À§Áø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 10:00~10:15 Device Therapies of Hypertension ±èº´±Ø(¿¬¼¼ÀÇ´ë)
Åä·Ð 11¿ù 03ÀÏ ROOM A 10:15~10:30 Åä·Ð Á¶ÀÎÁ¤, ÃÖ¼ºÈÆ, Çã¶õ(ÀÌÈÀÇ´ë, ÇѸ²ÀÇ´ë, ÇѾçÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 10:50~11:10 Intensive Treatment Strategy in Hypertension Áö¿µ¹Ì(Áúº´°ü¸®Ã»Àå)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM D 11:20~11:35 °íÇ÷¾Ð ȯÀÚÀÇ Ç¥ÀûÀå±â ¼Õ»ó Æò°¡ Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM D 11:35~11:50 °íÇ÷¾Ð ȯÀÚÀÇ Ç÷¾Ð ÃøÁ¤ ÀÌÀº¹Ì(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM D 11:50~12:05 °íÇ÷¾Ð ȯÀÚÀÇ ÈçÇÑ Áú¹®°ú ´ë´ä ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
Åä·Ð 11¿ù 03ÀÏ ROOM D 12:05~12:30 Åä·Ð ÀÓ»óÇö, ÇÏÁ¾¿ø(°¡Å縯ÀÇ´ë, ¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 12:40~13:10 Importance of 24h BP Control for Reducing CVD Risk: The Role of Edarbi À̼÷Áø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 13:35~13:50 Prevalence and Management of Hypertension in the US Daichi Shimbo(USA)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 13:50~14:05 Prevalence and Management of Hypertension in Europe Neil Poulter(UK)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 14:05~14:20 Prevalence and Management of Hypertension in Singapore Chadachan Veerendra(Singapore)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 14:20~14:35 Prevalence and Management of Hypertension in Korea ÀÌÈ£±Ô(¿¬¼¼ÀÇ´ë)
Åä·Ð 11¿ù 03ÀÏ ROOM A 14:35~14:50 Åä·Ð ±èÇзÉ, ÀÌÁÖ¹Ì(¼¿ïÀÇ´ë, Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:00~15:15 Association between BP Variability and Ischemic Stroke ÀÌÈñ¼±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:15~15:30 BP Variability and Parkinson ±Ç°âÀÏ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:30~15:45 BP Management in Patient with Cognitive Impairment/Dementia ±èÇöÁø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:45~16:00 Evolved Adaptations in the Giraffe : A Blueprint for Biomedical Innovation Babara Natterson-Horowitz(USA)
Åä·Ð 11¿ù 03ÀÏ ROOM A 16:00~16:15 Åä·Ð ±è¹üÁØ, ¹è´ëȯ(¿ï»êÀÇ´ë, ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 16:25~16:40 Chronic Kidney Disease and Hypertension : New Clinical Updates Á¤¼ºÁø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 16:40~16:55 Hypertension and Stroke in Asia Yuda Turana(Indonesia)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 16:55~17:10 Impact of Anti-hypertensive Therapy on Cerebral Function Networks and Connectivity Giuseppe Lembo(Italy)
±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 17:10~17:25 Hypertension Management in AF Patients ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë)
Åä·Ð 11¿ù 03ÀÏ ROOM A 17:25~17:40 Åä·Ð ¼Çý¼±, ÀÓÀ缺, õ´ë¿µ(¼øõÇâÀÇ´ë, ¿ï»êÀÇ´ë, ÇѸ²ÀÇ´ë)